Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: A 10-year community-based cohort study

European Journal of Endocrinology

Volumn 171, Issue 5, 2014, Pages 649-657

  Kim, Tae Hyuk ^a   Choi, Hoon Sung ^a   Bae, Ji Cheol ^b   Moon, Jae Hoon ^c   Kim, Hyung Kwan ^a   Choi, Sung Hee ^c   Lim, Soo ^c   Park, Do Joon ^a   Park, Kyong Soo ^a   Jang, Hak Chul ^c   Lee, Moon Kyu ^b   Cho, Nam H ^d   Park, Young Joo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGE; ANGINA PECTORIS; ANTIBODY BLOOD LEVEL; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; REYNOLDS RISK SCORE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; AGED; ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; COMPLICATION; DEMOGRAPHY; HYPOTHYROIDISM; METHODOLOGY; MIDDLE AGED; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PROGNOSIS; RESEARCH DESIGN; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84910110820     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0464     Document Type: Article

References (44)

1. Minino AM, Murphy SL, Xu J & Kochanek KD. Deaths: final data for 2008. National Vital Statistics Reports 2011 59 1-126.
2. Korea National Statistical Office. Annual Report on the Cause of Death Statistics in 2012. Seoul: Korea National Statistical Office, 2013.
3. Ridker PM, Buring JE, Rifai N & Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. Journal of the American Medical Association 2007 297 611-619. (doi:10.1001/jama.297.6.611)
4. Stone NJ, Robinson JG, Lichtenstein AH, BaireyMerz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2014 63 2889-2934. (doi:10.1016/j.jacc.2013.11.002)
5. Asvold BO, Bjoro T, Nilsen TI & Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. Journal of Clinical Endocrinology and Metabolism 2007 92 841-845. (doi:10.1210/jc.2006-2208)
6. Asvold BO, Vatten LJ, Nilsen TI & Bjoro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. European Journal of Endocrinology 2007 156 181-186. (doi:10.1530/eje.1.02333)
7. Cooper DS & Biondi B. Subclinical thyroid disease. Lancet 2012 379 1142-1154. (doi:10.1016/S0140-6736(11)60276-6)
8. Leese GP, Flynn RV, Jung RT, Macdonald TM, Murphy MJ & Morris AD. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clinical Endocrinology 2008 68 311-316.
9. Tseng FY, Lin WY, Lin CC, Lee LT, Li TC, Sung PK & Huang KC. Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. Journal of the American College of Cardiology 2012 60 730-737. (doi:10.1016/j.jacc.2012.03.047)
10. Choi SH, Kim TH, Lim S, Park KS, Jang HC & Cho NH. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011 34 944-949. (doi:10.2337/dc10-0644)
11. Cho NH, Choi HS, Kim KW, Kim HL, Lee SY, Choi SH, Lim S, Park YJ, Park do J, Jang HC et al. Interaction between cigarette smoking and iodine intake and their impact on thyroid function. Clinical Endocrinology 2010 73 264-270.
12. Kim TH, Kim KW, Ahn HY, Choi HS, Won H, Choi Y, Cho SW, Moon JH, Yi KH, Park do J et al. Effect of seasonal changes on the transition between subclinical hypothyroid and euthyroid status. Journal of Clinical Endocrinology and Metabolism 2013 98 3420-3429. (doi:10.1210/jc.2013-1607)
13. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Journal of the American Medical Association 2010 304 1365-1374. (doi:10.1001/jama.2010.1361)
14. Giri A, Edwards TL, LeGrys VA, Lorenz CE, Funk MJ, Schectman R, Heiss G, Robinson JG & Hartmann KE. Subclinical hypothyroidism and risk for incident ischemic stroke among postmenopausal women. Thyroid 2014 24 1210-1217. (doi:10.1089/thy.2014.0106)
15. American Diabetes Association. Executive summary: standards of medical care in diabetes - 2013. Diabetes Care 2013 36 (Suppl 1) S4-S10. (doi:10.2337/dc13-S004)
16. Berry SD, Samelson EJ, Pencina MJ, McLean RR, Cupples LA, Broe KE & Kiel DP. Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. Journal of the American Medical Association 2013 310 1256-1262. (doi:10.1001/jama.2013.277817)
17. Rhee CM, Alexander EK, Bhan I & Brunelli SM. Hypothyroidism and mortality among dialysis patients. Clinical Journal of the American Society of Nephrology 2013 8 593-601. (doi:10.2215/CJN.06920712)
18. PencinaMJ, D'Agostino RB Sr, D'Agostino RB Jr & Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine 2008 27 157-172. (doi:10.1002/sim.2929)
19. U.S. Preventive Services Task Force. Screening for thyroid disease: recommendation statement. Annals of Internal Medicine 2004 140 125-127. (doi:10.7326/0003-4819-140-2-200401200-00014)
20. Franklyn JA & Boelaert K. Subclinical thyroid disease: where is the evidence? Lancet Diabetes & Endocrinology 2013 1 172-173. (doi:10.1016/S2213-8587(13)70030-5)
21. Meyerovitch J, Rotman-Pikielny P, Sherf M, Battat E, Levy Y & Surks MI. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Archives of Internal Medicine 2007 167 1533-1538. (doi:10.1001/archinte.167.14.1533)
22. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA & McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Journal of Clinical Endocrinology and Metabolism 2005 90 581-585 discussion 586-587. (doi:10.1210/jc.2004-1231)
23. Nakajima Y, Yamada M, Akuzawa M, Ishii S, Masamura Y, Satoh T, Hashimoto K, Negishi M, Shimomura Y, Kobayashi I et al. Subclinical hypothyroidism and indices for metabolic syndrome in Japanese women: one-year follow-up study. Journal of Clinical Endocrinology and Metabolism 2013 98 3280-3287. (doi:10.1210/jc.2013-1353)
24. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D'Agostino RB Sr et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. New England Journal of Medicine 2008 359 2208-2219. (doi:10.1056/NEJMoa0804742)
25. Park YJ, Lee YJ, Choi SI, Chun EJ, Jang HC & Chang HJ. Impact of subclinical hypothyroidism on the coronary artery disease in apparently healthy subjects. European Journal of Endocrinology 2011 165 115-121. (doi:10.1530/EJE-11-0014)
26. Marfella R, Ferraraccio F, Rizzo MR, PortogheseM, Barbieri M, Basilio C, Nersita R, Siniscalchi LI, Sasso FC, Ambrosino I et al . Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2011 96 1015-1020. (doi:10.1210/jc.2010-1382)
27. Pasqualetti G, Tognini S, Polini A, Caraccio N & Monzani F. Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? Journal of Clinical Endocrinology and Metabolism 2013 98 2256-2266. (doi:10.1210/jc.2012-3818)
28. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M & Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. Journal of the American Medical Association 2004 292 2591-2599. (doi:10.1001/jama.292.21.2591)
29. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA & Woeber KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice 2012 18 988-1028. (doi:10.4158/EP12280.GL)
30. Villar HC, Saconato H, Valente O & Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database of Systematic Reviews 2007 3 CD003419.
31. Razvi S, Weaver JU, Butler TJ & Pearce SH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Archives of Internal Medicine 2012 172 811-817.
32. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson P, Benjamin EJ & D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine 1994 331 1249-1252. (doi:10.1056/NEJM199411103311901)
33. Kvetny J, Heldgaard PE, Bladbjerg EM & Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clinical Endocrinology 2004 61 232-238. (doi:10.1111/j.1365-2265.2004.02088.x)
34. Lindeman RD, Romero LJ, Schade DS, Wayne S, Baumgartner RN & Garry PJ. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Thyroid 2003 13 595-600. (doi:10.1089/105072503322238863)
35. Kim HC, Greenland P, Rossouw JE,Manson JE, Cochrane BB, Lasser NL, Limacher MC, Lloyd-Jones DM, Margolis KL & Robinson JG. Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. Journal of the American College of Cardiology 2010 55 2080-2091. (doi:10.1016/j.jacc.2009.12.047)
36. Cook NR & Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Annals of Internal Medicine 2009 150 795-802. (doi:10.7326/0003-4819-150-11-200906020-00007)
37. Tzoulaki I, Liberopoulos G & Ioannidis JP. Assessment of claims of improved prediction beyond the Framingham risk score. Journal of the American Medical Association 2009 302 2345-2352. (doi:10.1001/jama.2009.1757)
38. Kim YA & Park YJ. Prevalence and risk factors of subclinical thyroid disease. Endocrinology and Metabolism 2014 29 20-29. (doi:10.3803/EnM.2014.29.1.20)
39. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E & Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. Journal of Clinical Endocrinology and Metabolism 1998 83 765-769. (doi:10.1210/jcem.83.3.4624)
40. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Volzke H et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Archives of Internal Medicine 2012 172 799-809. (doi:10.1001/archinternmed.2012.402)
41. Wollenweber FA, Zietemann V, Gschwendtner A, Opherk C & Dichgans M. Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke. Stroke 2013 44 1446-1448. (doi:10.1161/STROKEAHA.113.000833)
42. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S & Wemeau JL. ETA guideline: management of subclinical hypothyroidism. European Thyroid Journal 2013 2 215-228. (doi:10.1159/000356507)
43. Hyland KA, Arnold AM, Lee JS & Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. Journal of Clinical Endocrinology and Metabolism 2013 98 533-540. (doi:10.1210/jc.2012-2180)
44. Cooney MT, Dudina AL & Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. Journal of the American College of Cardiology 2009 54 1209-1227. (doi:10.1016/j.jacc.2009.07.020)